# Astex Pharmaceuticals

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/astex-pharmaceuticals

- Industry: Pharmaceuticals
- Headquarters: Cambridge, UK
- Website: http://www.astex-therapeutics.com
- Total disclosed funding: $87M
- Latest round: Series C (Jun 13, 2008)
- Investors on record: 6

## About

Founded in 1999 and based in Cambridge, UK, Astex Pharmaceuticals Inc. is a biotechnology company that develops small molecule therapeutics for the treatment of cancer using a fragment-based drug discovery platform Pyramid.

The company is formerly known as Astex Therapeutics and changed its name to Astex Pharmaceuticals Inc. in April 2011 through a merger with SuperGen, Inc.

## Funding rounds

- Series C, Jun 13, 2008, $15M — Johnson & Johnson Innovation
- Series B, Oct 31, 2003, $17M — Abingworth, Advent International, Alta Partners, Oxford Bioscience Partners, Gimv
- Series B, Oct 30, 2003, $13M — Abingworth, Advent International, Alta Partners, Oxford Bioscience Partners, Gimv
- Series A, Sep 17, 2001, $8.7M — Abingworth, Advent International, Alta Partners, Oxford Bioscience Partners, Gimv
- Series A, Apr 24, 2001, $32M — Advent International, Alta Partners, Gimv

## Investors

- Advent International (https://capitalatlas.ai/funds/advent-international) — Series A, Series B
- Alta Partners (https://capitalatlas.ai/funds/alta-partners) — Series A, Series B
- Gimv (https://capitalatlas.ai/funds/gimv) — Series A, Series B
- Abingworth (https://capitalatlas.ai/funds/abingworth) — Series A, Series B
- Oxford Bioscience Partners (https://capitalatlas.ai/funds/oxford-bioscience-partners) — Series A, Series B
- Johnson & Johnson Innovation (https://capitalatlas.ai/funds/johnson-johnson-innovation) — Series C